GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.
"FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 drugs, including ...
Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...
Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...
Weight loss drugs like Ozempic and Wegovy have seemingly taken over this year, curbing users appetites by making them feel ...
Independence Blue Cross said starting Jan. 1 it will only be covering GLP-1 agonists — commonly sold under brand names like ...
More than half a million people are buying weight-loss injections online because of the “slow” rollout of the drugs by the ...
Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback